Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.390
-0.010 (-0.42%)
At close: May 8, 2026, 4:00 PM EDT
2.500
+0.110 (4.60%)
After-hours: May 8, 2026, 5:25 PM EDT
Fortress Biotech Employees
Fortress Biotech had 78 employees as of December 31, 2025. The number of employees decreased by 23 or -22.77% compared to the previous year.
Employees
78
Change (1Y)
-23
Growth (1Y)
-22.77%
Revenue / Employee
$811,051
Profits / Employee
-$24,128
Market Cap
79.39M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 78 | -23 | -22.77% |
| Dec 31, 2024 | 101 | -85 | -45.70% |
| Dec 31, 2023 | 186 | -1 | -0.53% |
| Dec 31, 2022 | 187 | 14 | 8.09% |
| Dec 31, 2021 | 173 | 62 | 55.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| TScan Therapeutics | 142 |
| Acrivon Therapeutics | 76 |
| PolyPid | 75 |
| Pliant Therapeutics | 49 |
| eXoZymes | 32 |
| Gain Therapeutics | 21 |
| Rallybio | 14 |
FBIO News
- 3 days ago - Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026 - GlobeNewsWire
- 6 days ago - Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference - GlobeNewsWire
- 19 days ago - Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™ - GlobeNewsWire
- 5 weeks ago - Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 5 weeks ago - Fortress Biotech's Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million - GlobeNewsWire
- 6 weeks ago - Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 7 weeks ago - Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026 - GlobeNewsWire
- 2 months ago - UPDATE: Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million - GlobeNewsWire